Gene · 10683
Papers2,335
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,335
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-drug conjugates in prostate cancer: current landscape and future directions. | Ther Adv Med Oncol | 2026 | 41883865 | PubTator, text mining | PubMed |
| Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. | Ann Med | 2026 | 41869709 | PubTator, text mining | PubMed |
| Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade. | Proc Natl Acad Sci U S A | 2026 | 41860961 | PubTator, text mining | PubMed |
| Jagged1 regulates extracellular matrix deposition and remodeling in triple-negative breast cancer. | Sci Adv | 2026 | 41849611 | PubTator, text mining | PubMed |
| Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities. | Genome Med | 2026 | 41845530 | PubTator, text mining | PubMed |
| Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. | Sci Adv | 2026 | 41824576 | PubTator, text mining | PubMed |
| Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | 41799520 | PubTator, text mining | PubMed |
| Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. | J Pharm Anal | 2026 | 41798069 | PubTator, text mining | PubMed |
| Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer. | Front Immunol | 2026 | 41789080 | PubTator, text mining | PubMed |
| Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer. | JCO Precis Oncol | 2026 | 41785440 | PubTator, text mining | PubMed |
| Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study. | JTO Clin Res Rep | 2026 | 41783745 | PubTator, text mining | PubMed |
| PGK1 Lactylation-Driven Self-Reinforcing Loop Orchestrates Glycolytic Reprogramming in FSP1+ Macrophages in Liver Fibrosis. | Research (Wash D C) | 2026 | 41783047 | PubTator, text mining | PubMed |
| Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis. | Front Immunol | 2026 | 41766905 | PubTator, text mining | PubMed |
| NCF2 facilitates M2 macrophage polarization in glioblastoma through activation of the notch1-osteopontin axis. | Front Immunol | 2026 | 41766892 | PubTator, text mining | PubMed |
| Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration. | Int J Oral Sci | 2026 | 41765949 | PubTator, text mining | PubMed |
| Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities. | Cancer | 2026 | 41761743 | PubTator, text mining | PubMed |
| A molecular and spatial resource defining tubulin isotype organization during corneal development. | bioRxiv | 2026 | 41756856 | PubTator, text mining | PubMed |
| A Machine Learning-Enabled Venom Peptide Platform for Rapid Drug Discovery. | Pharmaceuticals (Basel) | 2026 | 41754828 | PubTator, text mining | PubMed |
| A Splice Acceptor Variant in DLL3 Is Associated with Spondylocostal Dysostosis in a Litter of Mixed-Breed Dogs. | Genes (Basel) | 2026 | 41751515 | PubTator, text mining | PubMed |
| Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. | Curr Issues Mol Biol | 2026 | 41751395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10683/papers?page=6